Sangamo, Pfizer partner for ALS therapy

Sangamo Therapeutics Inc. (NASDAQ:SGMO) and Pfizer Inc. (NYSE:PFE) partnered to develop a therapy using Sangamo's zinc finger protein transcription factor (ZFP-TF)

Read the full 211 word article

User Sign In